“Yes,” says Dr. Donald Weaver, co-Director of the Krembil Brain Institute and author of new research published in the peer-reviewed journal, Alzheimer’s & Dementia. “We don’t think of Alzheimer’s as fundamentally a disease of the brain. We think of it […]
Big Alzheimer’s disease news this week: positive results for an anti-amyloid therapy. Researcher Derek Lowe takes a more sober view: “As the world knows, the anti-amyloid clinical landscape for Alzheimer’s is absolutely littered with failures in every direction: anti-amyloid antibodies […]
“A new study has uncovered a previously unknown hairpin-like structure within this protein that proved critical to an antibody response seen in mice, with an engineered version of the protein fragment also laying the groundwork for a vaccine against the […]
The approval came despite the advisory committee’s near-unanimous vote against it. “The approval, however, will do little to quell criticisms from the swath of Alzheimer’s researchers, biostatisticians, and clinicians who have argued that Biogen cherry-picked data and failed to show […]
“Researchers disclosed a potentially useful biomarker for Alzheimer’s Disease at a major conference this summer. The good news for clinical laboratories is that the biomarker is found in blood. If further research confirms these early findings, medical laboratories could one […]
“Scientists in Australia have made an exciting breakthrough in Alzheimer’s research, demonstrating what they describe as the first gene-therapy-based approach for treating advanced forms of the disease.” | learn more
“A new study from MIT has found that reactivating a certain enzyme improves repair of DNA damage in neurons, which helps Alzheimer’s patients and others with cognitive decline.” | learn more
“Researchers corrected synaptic dysfunctions in the brain involved in memory loss, using an epigenetic approach.” | learn more
“Alongside new discoveries in gut-brain communication and the genesis of Alzheimer’s disease, the FDA advanced acceptance of psychedelic medicines, from psilocybin to marijuana.” | learn more
Basically, the only things he works on are big ideas, so this fits nicely here. “Bill Gates looks back on 2018, and shares a few thoughts on what’s going well and what isn’t with innovation in some specific areas that […]